Predicting platelet age in an intelligent way

• Conditions: low platelet count; thrombocytopenia; 10035534

• Registration Number: NL-OMON53631
• Lead Sponsor: Erasmus MC, Universitair Medisch Centrum Rotterdam

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 9 April 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 8

Inclusion Criteria

Part 1:
Patients diagnosed with Lowe syndrome
All ages

Part 2:
Patients diagnosed with AML
After first remission induction (RI) cycle
In complete remission after first RI cycle

Exclusion Criteria

Part 1:
patients with a known bleeding disorder
Unwilling to give informed consent
Patients using anticoagulants

Part 2:
patients receiving platelet transfusion in the study period
unwilling to give informed consent
Patients using anticoagulants

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>For Part 1 as well as Part 2: platelet characteristics using staining of alpha<br /><br>tubulin and VWF and SPARC.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>NA</p>